Correlation Between Medigen Biotechnology and Universal Vision

Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and Universal Vision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and Universal Vision into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medigen Biotechnology and Universal Vision Biotechnology, you can compare the effects of market volatilities on Medigen Biotechnology and Universal Vision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of Universal Vision. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and Universal Vision.

Diversification Opportunities for Medigen Biotechnology and Universal Vision

0.88

Correlation Coefficient

Medigen Biotechnology  Universal Vision

Very poor diversification

The 3 months correlation between Medigen and Universal is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and Universal Vision Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universal Vision Bio and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with Universal Vision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universal Vision Bio has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and Universal Vision go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and Universal Vision

Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the Universal Vision. In addition to that, Medigen Biotechnology is 1.06 times more volatile than Universal Vision Biotechnology. It trades about -0.17 of its total potential returns per unit of risk. Universal Vision Biotechnology is currently generating about -0.16 per unit of volatility. If you would invest  23,150  in Universal Vision Biotechnology on October 10, 2024 and sell it today you would lose (3,000) from holding Universal Vision Biotechnology or give up 12.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Medigen Biotechnology  vs.  Universal Vision Biotechnology

Medigen Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Universal Vision Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Universal Vision Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Medigen Biotechnology and Universal Vision

The main advantage of trading using opposite Medigen Biotechnology and Universal Vision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, Universal Vision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Vision will offset losses from the drop in Universal Vision's long position.

The idea behind Medigen Biotechnology and Universal Vision Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.